In our portfolio of dozens of startups and companies, Tekedia Capital chooses Revna Biosciences as the best portfolio company of Feb 2025. Revna Biosciences is a premier precision medicine research company based in Ghana, known for its advanced molecular diagnostic services and clinical research.
The company stands as a beacon of precision medicine innovation in West Africa, offering state-of-the-art molecular diagnostics and driving a significant paradigm shift in advanced molecular diagnostics across the African continent. It is an active member of the American Association for Laboratory Accreditation (A2LA).
Revnabio will be starting operations also in Nigeria later this year. Its services are saving lives. Tekedia Capital led the first and second funding rounds of this company and remain proud of our efforts to fund catalytic projects in Africa.
Register for Tekedia Mini-MBA edition 17 (June 9 – Sept 6, 2025) today for early bird discounts. Do annual for access to Blucera.com.
Tekedia AI in Business Masterclass opens registrations.
Join Tekedia Capital Syndicate and co-invest in great global startups.
Register to become a better CEO or Director with Tekedia CEO & Director Program.
---
Register for Tekedia Mini-MBA (June 9 – Sept 6, 2025), and join Prof Ndubuisi Ekekwe and our global faculty; click here.